Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sheehan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Medicine|December 11, 2012
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trialVivian A Fonseca, Lawrence A Lavery, Tina K Thethi, et al.
Lancet (London, England)|April 9, 2018
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment servicesMelanie Y Bertram, Kim Sweeny, Jeremy A Lauer, et al.
American Journal of Surgery|December 26, 2006
Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical studyThomas E Lyons, Michael S Miller, Thomas Serena, et al.
Annals of the New York Academy of Sciences|December 9, 2024
New York State Climate Impacts Assessment Chapter 06: EnergySandra Meier, Peter J Marcotullio, Peter Carney, et al.
Lancet (London, England)|April 24, 2017
Building the foundations for sustainable development: a case for global investment in the capabilities of adolescentsPeter Sheehan, Kim Sweeny, Bruce Rasmussen, et al.
Nature|February 23, 2018
Adolescence and the next generationGeorge C Patton, Craig A Olsson, Vegard Skirbekk, et al.
Nature|May 4, 2018
Publisher Correction: Adolescence and the next generationGeorge C Patton, Craig A Olsson, Vegard Skirbekk, et al.
Lancet (London, England)|November 23, 2013
Advancing social and economic development by investing in women's and children's health: a new Global Investment FrameworkKarin Stenberg, Henrik Axelson, Peter Sheehan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Medicine|December 11, 2012
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trialVivian A Fonseca, Lawrence A Lavery, Tina K Thethi, et al.
Lancet (London, England)|April 9, 2018
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment servicesMelanie Y Bertram, Kim Sweeny, Jeremy A Lauer, et al.
American Journal of Surgery|December 26, 2006
Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical studyThomas E Lyons, Michael S Miller, Thomas Serena, et al.
Annals of the New York Academy of Sciences|December 9, 2024
New York State Climate Impacts Assessment Chapter 06: EnergySandra Meier, Peter J Marcotullio, Peter Carney, et al.
Lancet (London, England)|April 24, 2017
Building the foundations for sustainable development: a case for global investment in the capabilities of adolescentsPeter Sheehan, Kim Sweeny, Bruce Rasmussen, et al.
Nature|February 23, 2018
Adolescence and the next generationGeorge C Patton, Craig A Olsson, Vegard Skirbekk, et al.
Nature|May 4, 2018
Publisher Correction: Adolescence and the next generationGeorge C Patton, Craig A Olsson, Vegard Skirbekk, et al.
Lancet (London, England)|November 23, 2013
Advancing social and economic development by investing in women's and children's health: a new Global Investment FrameworkKarin Stenberg, Henrik Axelson, Peter Sheehan, et al.
Pageof 3